Table of Contents
Chapter 1. Global mRNA Vaccines and Therapeutics Market Executive Summary
1.1. Global mRNA Vaccines and Therapeutics Market Size & Forecast (2022- 2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Vaccine Type
1.3.2. By Application
1.3.3. By Treatment Type
1.3.4. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global mRNA Vaccines and Therapeutics Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global mRNA Vaccines and Therapeutics Market Dynamics
3.1. Market Drivers
3.1.1. Rising prevalence of chronic and infectious diseases
3.1.2. Growth in R&D activities and strategic partnerships
3.1.3. Increased demand for new vaccines and therapeutics
3.2. Market Challenges
3.2.1. Regulatory framework for market authorization
3.2.2. High production costs and infrastructure requirements
3.3. Market Opportunities
3.3.1. Expansion into emerging markets
3.3.2. Technological advancements in mRNA synthesis and manufacturing
3.3.3. Rising investment from both public and private sectors
Chapter 4. Global mRNA Vaccines and Therapeutics Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global mRNA Vaccines and Therapeutics Market Size & Forecasts by Vaccine Type 2022-2032
5.1. Segment Dashboard
5.2. Global mRNA Vaccines and Therapeutics Market: Vaccine Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Self-amplifying mRNA-based Vaccines
5.2.2. Conventional Non-amplifying mRNA-based Vaccines
Chapter 6. Global mRNA Vaccines and Therapeutics Market Size & Forecasts by Application 2022-2032
6.1. Segment Dashboard
6.2. Global mRNA Vaccines and Therapeutics Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Cancer
6.2.2. Infectious Diseases
6.2.3. Autoimmune Diseases
6.2.4. Other Applications
Chapter 7. Global mRNA Vaccines and Therapeutics Market Size & Forecasts by Treatment Type 2022-2032
7.1. Segment Dashboard
7.2. Global mRNA Vaccines and Therapeutics Market: Treatment Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Monoclonal Antibody
7.2.2. Gene Therapy
7.2.3. Cell Therapy
7.2.4. Other Treatment Types
Chapter 8. Global mRNA Vaccines and Therapeutics Market Size & Forecasts by End User 2022-2032
8.1. Segment Dashboard
8.2. Global mRNA Vaccines and Therapeutics Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Research Laboratories and Organizations
8.2.2. Hospitals and Clinics
8.2.3. Other End Users
Chapter 9. Global mRNA Vaccines and Therapeutics Market Size & Forecasts by Region 2022-2032
9.1. North America mRNA Vaccines and Therapeutics Market
9.1.1. U.S. mRNA Vaccines and Therapeutics Market
9.1.1.1. Vaccine Type breakdown size & forecasts, 2022-2032
9.1.1.2. Application breakdown size & forecasts, 2022-2032
9.1.1.3. Treatment Type breakdown size & forecasts, 2022-2032
9.1.1.4. End User breakdown size & forecasts, 2022-2032
9.1.2. Canada mRNA Vaccines and Therapeutics Market
9.2. Europe mRNA Vaccines and Therapeutics Market
9.2.1. U.K. mRNA Vaccines and Therapeutics Market
9.2.2. Germany mRNA Vaccines and Therapeutics Market
9.2.3. France mRNA Vaccines and Therapeutics Market
9.2.4. Spain mRNA Vaccines and Therapeutics Market
9.2.5. Italy mRNA Vaccines and Therapeutics Market
9.2.6. Rest of Europe mRNA Vaccines and Therapeutics Market
9.3. Asia-Pacific mRNA Vaccines and Therapeutics Market
9.3.1. China mRNA Vaccines and Therapeutics Market
9.3.2. India mRNA Vaccines and Therapeutics Market
9.3.3. Japan mRNA Vaccines and Therapeutics Market
9.3.4. Australia mRNA Vaccines and Therapeutics Market
9.3.5. South Korea mRNA Vaccines and Therapeutics Market
9.3.6. Rest of Asia Pacific mRNA Vaccines and Therapeutics Market
9.4. Latin America mRNA Vaccines and Therapeutics Market
9.4.1. Brazil mRNA Vaccines and Therapeutics Market
9.4.2. Mexico mRNA Vaccines and Therapeutics Market
9.4.3. Rest of Latin America mRNA Vaccines and Therapeutics Market
9.5. Middle East & Africa mRNA Vaccines and Therapeutics Market
9.5.1. Saudi Arabia mRNA Vaccines and Therapeutics Market
9.5.2. South Africa mRNA Vaccines and Therapeutics Market
9.5.3. Rest of Middle East & Africa mRNA Vaccines and Therapeutics Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Pfizer Inc.
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Market Strategies
10.3.2. Moderna, Inc.
10.3.3. BioNTech SE
10.3.4. GlaxoSmithKline
10.3.5. Daiichi Sankyo
10.3.6. Ribometrix Inc.
10.3.7. Genentech
10.3.8. Eli Lilly and Company
10.3.9. Strand Therapeutics
10.3.10. CureVac N.V.
10.3.11. Arcturus Therapeutics
10.3.12. Translate Bio
10.3.13. Alnylam Pharmaceuticals
10.3.14. Sanofi
10.3.15. AstraZeneca
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes